Rayan Sadri is a product and growth lead with a background in AI and NLP. I cofounded Carez AI, a venture backed startup that builds data platforms for computer vision teams. I led product, growth, and partnerships across North America and Europe. We were selected into ERA NYC, CDL AI, and NEXT36.
I like small teams that ship. My work bridges data infrastructure, model evaluation, and clinical workflows with enterprise sales and onboarding. I run tight discovery, move fast to a minimum lovable product, and keep a clean surface for buyers.
Product strategy
Zero to private beta in eight weeks
▸
Tight discovery to a minimum lovable product.
- PRD to release cadence of four drops per month
- Clear acceptance criteria and rollback plans
- Roadmap runs on user outcomes and cost of delay
Growth and GTM
Founder led sales from discovery to references
▸
- Five hundred K plus pipeline built from discovery
- Eleven design partners onboarded, twenty plus on waitlist
- ACV and pilot pricing tested with fast loops
Data and AI
Evaluation frameworks that buyers trust
▸
- Strong with Python, SQL, model tooling and benchmarks
- Human in the loop review designed for quality
- Simple metrics that predict deployment success
UX and research
One screen and one action for clinicians
▸
- Observation first studies with decision logs in twenty four hours
- Specs written from real tasks, not features
- Figma prototypes that match production constraints
Enterprise and partnerships
Pilots across Canada, Brazil, United States
▸
- External validation via ERA NYC, CIRSE, GEST, universities
- Security questionnaires and IRB ready data flows
- Buyer committee mapped, risks owned early
Team leadership
Five people across three time zones
▸
- Weekly operating rhythm with clear ownership
- Decision memos under one page within a day
- Calm incident reviews and no blame fixes
Ops and quality
Runbooks that match real clinical use
▸
- Logging and audit trails buyers accept
- Release checklists and easy rollbacks
- Success criteria tied to clinical and business outcomes
Storytelling and fundraising
Clear wedge to platform story
▸
- ERA NYC one percent acceptance, demo to 400 plus investors
- Press and talks that build buyer trust
- Data room and FAQs ready for diligence
2025 United Nations WIPO Conversation Talk Open ↗
Invited speaker on synthetic medical data and ethics.
2025 AI for Pharma Growth Podcast Open ↗
Scaling synthetic imaging for clinical validation.
2025 McGill Delve Interview Podcast Open ↗
Inside a startup using AI for medical imaging.
2024 ERA NYC Demo Day Demo Open ↗
Pitched to 400 plus investors in New York City.
2024 ERA NYC Announcement Press Open ↗
Selected top one percent for Winter 2024 cohort.
2024 CIRSE Congress Feature Press Open ↗
Industry highlight for AI powered image enhancement.
2024 21st Century Tech Article Open ↗
Coverage of synthetic medical imaging tool.
2024 AI in Embolization Feature Open ↗
GEST Group spotlight.
- Data platform for computer vision teams in healthcare and life sciences
- Synthetic imaging datasets and validation workflows
- Backed by ERA NYC with pilots across North America and Latin America